CNW/ - IGM Financial Inc. (IGM) (TSX: IGM) today reported total assets under management and advisement of $310.1 billion at ...

As we enter 2026, investors are encouraged to reassess the health of both the Canadian and U.S. economies, especially given recent fluctuations in employment trends and inflation data. In this context ...

Dogma holds that plasma cells, as opposed to B cells, cannot bind antigen because they have switched from expression of membrane-bound immunoglobulins (Ig) that constitute the B-cell receptor (BCR) to ...

Sanofi has continued the breakneck pace of dealmaking activity, paying $150 million upfront to make IGM Biosciences the third partner added in a hectic month for its business development team. The ...

Natural IgM, a pentameric, polyreactive antibody, is mainly secreted by peritoneal B1 B cells and recognizes and binds self antigens such as phospholipids. The unique structure of natural IgM allows ...

IGM Biosciences ended last year laying off staff and streamlining its cancer pipeline. Now, the company has become the latest to join a hot trend in cell therapy biotech—pivoting from oncology to ...

IGM Financial (TSX:IGM) just reported a record CA$311.1 billion in assets under management and advisement, up roughly 14% year over year, with November net inflows of CA$753 million across IG Wealth ...

IGM Biosciences Inc. said Thursday it is cutting 73% of its workforce after deciding to halt further development of a program relating to its autoimmunity-drug pipeline, sending its stock down 69% in ...

IGM Biosciences announced they are halting the development of two investigational drugs for autoimmune and inflammatory diseases, imvotamab (an IgM-based CD20 X CD3 bispecific antibody T cell engager) ...

The country is seeing a massive dengue outbreak as thousands of cases are being reported monthly. This is a mosquito-borne illness that begins in the monsoon(mosquito ...